Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience.
Carr MJ, Sun J, DePalo D, Rothermel LD, Song Y, Straker RJ, Baecher K, Louie RJ, Stahlie EHA, Wright GP, Naqvi SMH, Kim Y, Sarnaik AA, Karakousis GC, Lowe MC, Delman KA, van Akkooi ACJ, Ollila DW, Collichio F, Zager JS.
Carr MJ, et al. Among authors: stahlie eha.
Ann Surg Oncol. 2022 Feb;29(2):791-801. doi: 10.1245/s10434-021-10910-5. Epub 2021 Oct 14.
Ann Surg Oncol. 2022.
PMID: 34648098